Home > Publications database > Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. > print

001     296020
005     20251112115731.0
024 7 _ |a 10.1002/cncr.35620
|2 doi
024 7 _ |a pmid:39711146
|2 pmid
024 7 _ |a 1934-662X
|2 ISSN
024 7 _ |a 0008-543X
|2 ISSN
024 7 _ |a 1045-7410
|2 ISSN
024 7 _ |a 1097-0142
|2 ISSN
024 7 _ |a 1934-6638
|2 ISSN
024 7 _ |a altmetric:172342778
|2 altmetric
037 _ _ |a DKFZ-2024-02763
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Nguyen, Timothy
|0 0009-0009-1571-8959
|b 0
245 _ _ |a Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
260 _ _ |a New York, NY
|c 2025
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1738246819_13605
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Jan 15;131(2):e35620
520 _ _ |a The relations between coffee and tea consumption and head and neck cancer (HNC) incidence are unclear. With increasing global HNC burden, this study aims to examine the association between coffee, tea, and HNC.A pooled analysis of 9548 HNC cases and 15,783 controls from 14 individual-level case-control studies was conducted from the International Head and Neck Cancer Epidemiology consortium. Random-effects logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for HNC and its subsites, adjusting for sociodemographic and lifestyle factors.Compared to non-coffee drinkers, drinking >4 cups of caffeinated coffee daily was inversely associated with HNC (OR, 0.83; 95% CI, 0.69-1.00), oral cavity (OR, 0.70; 95% CI, 0.55-0.89), and oropharyngeal cancers (OR, 0.78; 95% CI, 0.61-0.99). Drinking 3-4 cups of caffeinated coffee was inversely associated with hypopharyngeal cancer (OR, 0.59; 95% CI, 0.39-0.91). Drinking decaffeinated coffee and drinking between >0 to <1 cup daily were inversely associated with oral cavity cancer (OR, 0.75; 95% CI, 0.64-0.87 and OR, 0.66; 95% CI, 0.54-0.81). Drinking tea was inversely associated with hypopharyngeal cancer (OR, 0.71; 95% CI, 0.59-0.87). Daily tea consumption of >0 to ≤1 cup was inversely associated with HNC (OR, 0.91; 95% CI, 0.84-0.98) and hypopharyngeal cancer (OR, 0.73; 95% CI, 0.59-0.91), but drinking >1 cup was associated with laryngeal cancer (OR, 1.38; 95% CI, 1.09-1.74).These findings support reduced HNC risk among coffee and tea drinkers. Future studies are needed to address geographical differences in types of coffee and tea to improve our understanding of the association of coffee and tea and global HNC risk.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a coffee and tea
|2 Other
650 _ 7 |a head and neck cancer
|2 Other
650 _ 7 |a pooled analysis
|2 Other
700 1 _ |a Koric, Alzina
|0 0009-0003-9943-2945
|b 1
700 1 _ |a Chang, Chun-Pin Esther
|0 0000-0002-0878-997X
|b 2
700 1 _ |a Barul, Christine
|b 3
700 1 _ |a Radoi, Loredana
|b 4
700 1 _ |a Serraino, Diego
|b 5
700 1 _ |a Purdue, Mark P
|0 0000-0003-1177-3108
|b 6
700 1 _ |a Kelsey, Karl T
|b 7
700 1 _ |a McClean, Michael D
|b 8
700 1 _ |a Negri, Eva
|b 9
700 1 _ |a Edefonti, Valeria
|b 10
700 1 _ |a Moysich, Kirsten
|0 0000-0002-4678-2058
|b 11
700 1 _ |a Zhang, Zuo-Feng
|b 12
700 1 _ |a Morgenstern, Hal
|b 13
700 1 _ |a Levi, Fabio
|b 14
700 1 _ |a Vaughan, Thomas L
|b 15
700 1 _ |a La Vecchia, Carlo
|b 16
700 1 _ |a Garavello, Werner
|b 17
700 1 _ |a Hayes, Richard B
|b 18
700 1 _ |a Benhamou, Simone
|b 19
700 1 _ |a Schantz, Stimson P
|b 20
700 1 _ |a Yu, Guo-Pei
|b 21
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 22
|u dkfz
700 1 _ |a Chuang, Shu-Chun
|0 0000-0002-1190-5687
|b 23
700 1 _ |a Boffetta, Paolo
|0 0000-0002-3811-2791
|b 24
700 1 _ |a Hashibe, Mia
|b 25
700 1 _ |a Lee, Yuan-Chin Amy
|b 26
773 _ _ |a 10.1002/cncr.35620
|g p. cncr.35620
|0 PERI:(DE-600)1479932-7
|n 2
|p e35620
|t Cancer
|v 131
|y 2025
|x 0008-543X
856 4 _ |y OpenAccess
|u https://inrepo02.dkfz.de/record/296020/files/Cancer%20-%202024%20-%20Nguyen%20-%20Coffee%20and%20tea%20consumption%20and%20the%20risk%20of%20head%20and%20neck%20cancer%20An%20updated%20pooled%20analysis%20in%20the.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://inrepo02.dkfz.de/record/296020/files/Cancer%20-%202024%20-%20Nguyen%20-%20Coffee%20and%20tea%20consumption%20and%20the%20risk%20of%20head%20and%20neck%20cancer%20An%20updated%20pooled%20analysis%20in%20the.pdf?subformat=pdfa
909 C O |o oai:inrepo02.dkfz.de:296020
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER-AM CANCER SOC : 2022
|d 2023-10-21
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CANCER-AM CANCER SOC : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Primäre Krebsprävention
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21